首页> 外文期刊>Journal of human hypertension >Left ventricular and carotid structure in untreated, uncomplicated essential hypertension: results from the Assessment Prognostic Risk Observational Survey (APROS).
【24h】

Left ventricular and carotid structure in untreated, uncomplicated essential hypertension: results from the Assessment Prognostic Risk Observational Survey (APROS).

机译:未经治疗,简单的原发性高血压的左心室和颈动脉结构:评估预后风险观察调查(APROS)的结果。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The impact of hypertension on left ventricular (LV) and vascular structure and the relation of left ventricular hypertrophy (LVH) with vascular changes in untreated essential hypertensives has not been fully explored. This study investigated the prevalence of structural abnormalities of LV and carotid arteries and their determinants in a large population of untreated, uncomplicated essential hypertensive patients. The Assessment of Prognostic Risk Observational Survey was a multicentre (44 centres) prospective study including 1142 untreated hypertensives classified as low or medium cardiovascular risk on the basis of the routine diagnostic work-up recommended by the 1999 World Health Organization/International Society of Hypertension guidelines. All patients underwent ultrasound examinations of the heart and carotid arteries. LVH and carotid structural changes were diagnosed when: (1) LV mass index exceeded 125 g/m(2) in men and 110 g/m(2) in women; (2) there was at least one plaque (focal thickening>1.3 mm) in any segment of either carotid artery or a diffuse common carotid intima-media thickness (IMT) (average of IMT>/=0.8 mm) was present. Overall, 1074 patients (504 women, mean age 48.1+/-11.4 years) completed the study with ultrasonographic examinations of good technical quality. The prevalences of LVH and LV concentric remodelling in the total population were 26.8 and 10.7%, respectively. Eccentric hypertrophy was more prevalent than concentric hypertrophy (15.2 vs 11.6%). One or more carotid plaques or thickening were present in 27.4% of the patients. A stepwise increase in IM thickness occurred from the lowest values in patients with normal cardiac mass and geometry (0.68 mm) to intermediate in those with LV remodelling (0.76 mm) and eccentric LVH (0.81 mm) and to the highest level in patients with concentric LVH (0.87 mm). Patients with LV concentric remodelling and concentric LVH had a significantly greater relative carotid wall thickness than those with normal geometry and eccentric LVH (0.25 and 0.26 vs 0.18 and 0.19, respectively, P<0.01). According to a multivariate analysis age, blood glucose, systolic BP and pulse pressure were the main independent predictors of LVH, while age, systolic BP and total cholesterol were the variables with the greatest impact on IM thickening. To conclude, this study shows that: (1) altered patterns of LV structure and geometry and carotid structural changes occur in a large fraction of patients with untreated essential hypertension; (2) there is a significant association between carotid wall thickening and LVH; (3) the probability of LVH or carotid thickening is significantly greater in elderly, in patients with higher systolic BP and in patients with associated metabolic risk factors.
机译:高血压对未经治疗的原发性高血压患者左心室(LV)和血管结构的影响以及左心室肥大(LVH)与血管变化的关系尚未得到充分研究。这项研究调查了大量未经治疗,不复杂的原发性高血压患者的左室和颈动脉结构异常及其决定因素的患病率。 《预后风险评估观察评估》是一项多中心(44个中心)的前瞻性研究,其中包括根据1999年世界卫生组织/国际高血压学会指南建议的常规诊断检查,将1142例未经治疗的高血压归为中低心血管风险。所有患者均接受了心脏和颈动脉的超声检查。在以下情况下,可诊断出LVH和颈动脉结构改变:(1)男性的LV质量指数超过125 g / m(2),女性的LV质量指数超过110 g / m(2); (2)在颈动脉的任何节段或弥漫性颈总内膜中层厚度(IMT)(IMT均值> / = 0.8 mm)中均存在至少一个斑块(病灶增厚> 1.3 mm)。总体而言,有1074例患者(504名女性,平均年龄48.1 +/- 11.4岁)通过了具有良好技术质量的超声检查完成了本研究。 LVH和LV同心重塑在总人口中的患病率分别为26.8和10.7%。偏心肥大比同心肥大(15.2比11.6%)。 27.4%的患者存在一个或多个颈动脉斑块或增厚。 IM厚度逐渐增加,从具有正常心脏质量和几何形状的患者的最低值(0.68 mm)到左心室重塑(0.76 mm)和偏心LVH(0.81 mm)的中间值,到同心患者的最高水平LVH(0.87毫米)。 LV同心重塑和同心LVH患者的相对颈动脉壁厚明显高于正常几何和偏心LVH的患者(分别为0.25和0.26对0.18和0.19,P <0.01)。根据多变量分析,年龄,血糖,收缩压和脉压是LVH的主要独立预测因子,而年龄,收缩压和总胆固醇是对IM增厚影响最大的变量。总而言之,这项研究表明:(1)大部分未经治疗的原发性高血压患者左室结构和几何形状改变以及颈动脉结构改变; (2)颈动脉壁增厚与LVH之间存在显着关联; (3)LVH或颈动脉增厚的可能性在老年人,收缩压较高的患者以及有相关代谢危险因素的患者中更高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号